A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...

Please provide your email address to receive an email when new articles are posted on . More patients in the ED with hemoptysis saw an end to the condition with nebulized vs. IV tranexamic acid.

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

Local injection of tranexamic acid (TXA) effectively reduced the risk for clinically significant bleeding following Mohs micrographic surgery (MMS), results from a single-center cohort study showed.

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Please provide your email address to receive an email when new articles are posted on . This study reports results from a prospective, randomized, double-blind trial. Use of IV tranexamic acid did not ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market. The company plans to launch ...

Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of thromboembolic events -- including ...

Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the approval of an Abbreviated New Drug Application (ANDA) 1 for Tranexamic Acid Injection 1000 mg/10mL (100 mg/mL). The Food ...

Represents the Company’s tenth product launch since inception in October 2023 SCHAUMBURG, Ill., June 24, 2024--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying ...